Daily non-political popular news in brief.
Signal protein shows promise for blocking tumor promoters in skin cells
11-03-2006 · EurekAlert!A protein with the ironic name "Srcasm" can counteract the effects of tumor-promoting molecules in skin cells. Using animal models, the researchers discovered that Srcasm acts like a brake in epithelial cells, preventing uncontrolled cell growth caused by a family of proteins called Src kinases. This finding, published online in the Journal of Biological Chemistry, suggests a target for future gene therapy to treat skin, head, neck, colon and breast cancers.
Read more »
Keywords: signal, protein, shows, promise, blocking, tumor, promoters, skin, cells, show, promoter, cell
« Previous | Next »
Similar news on "Signal protein shows promise for blocking tumor promoters in skin cells":
- A tricky tumor virus
01-17-2008 · EurekAlert!
Viruses use many tricks to gain control over their host cells and to reprogram them to their own advantage. Dr. Arnd Kieser and his colleagues of the Department of Gene Vectors of the Helmholtz Zentrum Munich, Germany, were able to show in a recent publication in PLoS Biology by which mechanism Epstein-Barr virus exploits a signal protein of its host cell, which normally mediates programmed cell death, in order to convert the cell into a cancer cell.
Similar news · Read more »
- 'Modular' leukemia drug shows promise in early testing
06-28-2007 · EurekAlert!
A new type of engineered drug candidate has shown promise in treating chronic lymphocytic leukemia in both test tube and early animal tests, a new study shows. The agent represents a new class of agents called small modular immunopharmaceuticals. Called CD37-SMIP, the agent targets a protein called CD37 on the surface of these leukemia cells.
Similar news · Read more »
- Gold nanoparticle probes may allow earlier cancer detection
12-23-2007 · EurekAlert!
Using tiny gold particles embedded with dyes, researchers have shown that they can identify tumors under the skin of a living animal. These tools may allow doctors to detect and diagnose cancer earlier and less invasively. Studded with antibody fragments called ScFv peptides that bind cancer cells, the gold particles grab onto tumors after their injection into a mouse. When illuminated with a laser beam, the tumor-bound particles send back a signal that is specific to the dye.
Similar news · Read more »
- Mayo discovers protein as potential tactic to prevent tumors
10-12-2006 · EurekAlert!
Mayo Clinic researchers have found that a protein that initiates a "quality control check" during cell division also directs cell death for those cells damaged during duplication. This knowledge represents a potential "bulls eye" for targeting anti-tumor drugs. The findings appear in the current issue of Science.
Similar news · Read more »
- Taking a Jab at Cancer
08-11-2007 · Science News Online
Vaccines that train a person's immune system to kill cancerous cells, when combined with drugs that block tumor defense mechanisms, are starting to show promise.
Similar news · Read more »
- Regulatory T cells require WASp if they are to prevent self-destruction
01-11-2007 · EurekAlert!
In humans, mutation of the gene encoding a protein known as WASp leads to susceptibility to infections and systemic autoimmunity. Most studies have focused on understanding how WASp deficiency causes defects in T cell activation, but a new study shows that in mice and humans a population of T cells known as regulatory T cells, which prevent other immune cells attacking the body's and causing autoimmunity, are also impaired in the absence of WASp.
Similar news · Read more »
- Sidestepping cancer's chaperone
10-18-2007 · EurekAlert!
Researchers at the University of Massachusetts Medical School, have defined a method to target and kill cancer's 'chaperone' -- a protein that promotes tumor cell stability and survival -- without damaging healthy cells nearby.
Similar news · Read more »
- Role of TRPM8 in the development of prostate cancer
05-17-2007 · EurekAlert!
In normal prostate epithelium, cells coexist in many stages of development-differentiation, and disrupted differentiation and proliferation are major causes of cancer. A new study shows that the endoplasmic reticulum protein TRPM8 (ER-TRPM8) present in human prostate epithelial luminal cancer cells retains it’s function as a calcium release channel, independent of the differentiation state of the cell, and may be an important factor in controlling the growth of prostate cancer cells.
Similar news · Read more »
- Widespread support for nonembryonic stem cell research, VCU Life Sciences Survey shows
12-19-2007 · EurekAlert!
The VCU Life Sciences Survey is the first poll to reflect the discovery reported internationally in November that human skin cells can be used to create stem cells or their near equivalents. When asked about the implications of this development, more than six in 10, or 63 percent, say that both embryonic and nonembryonic stem cell research is still needed, 22 percent say this development means embryonic stem cell research is no longer necessary.
Similar news · Read more »
- Master regulatory gene of epithelial stem cells identified
05-03-2007 · EurekAlert!
The skin's ability to replace the tissue it sloughs off is controlled by a variety of genes. A new study from Harvard Medical School published in the May 4 issue of Cell, however, identifies a "master regulator" of this regeneration process not only for skin, but for many epithelial tissues including breast, prostate, and urogenital tract. This master regulator of epithelial stem cells turns out to be the p63 gene, a close relative to the well-known tumor-suppressing p53 gene.
Similar news · Read more »
